Lexaria Bioscience CEO outlines 2025 progress and 2026 plans

Go back to Lexaria Bioscience CEO outlines 2025 progress and 2026 plans
(NASDAQ: LEXX) Delayed: 0.57 +0.03 (5.56%)
Previous Close $0.54    52 Week High
Open $0.57    52 Week Low
Day High $0.60    P/E N/A 
Day Low $0.57    EPS
Volume 51,496       

(NASDAQ: LEXXW) Delayed: 0.00 --0 (-0%)
Previous Close $0.00    52 Week High
Open $0.00    52 Week Low
Day High $0.00    P/E N/A 
Day Low $0.00    EPS
Volume 10,116